PREDICT (Patient characteristics in Renal cell carcinoma and Daily practice Treatment with Nexavar) global non-interventional study: first interim results

被引：0
|
作者：
Jager, D. [1 ]
Ma, J. H. [2 ]
Korbenfeld, E. [3 ]
Zemanova, M. [4 ]
Leonhartsberger, N. [5 ]
Stauch, K. [6 ]
Boeckenhoff, A. [7 ]
Yu, J. [8 ]
Escudier, B. [9 ]
机构：
[1] Univ Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina
[4] Charles Univ Prague, Prague, Czech Republic
[5] Univ Innsbruck, A-6020 Innsbruck, Austria
[6] Bayer HealthCare, Leverkusen, Germany
[7] Bayer HealthCare, Wuppertal, Germany
[8] Bayer HealthCare, Montville, NJ USA
[9] Inst Gustave Roussy, Villejuif, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71461-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：431 / 432
页数：2
相关论文
共 50 条
  • [31] Evolocumab in clinical Practice in Austria: 6 Months Interim Data on Patient Characteristics, Efficacy and Tolerability from a European, non-interventional Study
    Drexel, Heinz
    Toplak, Hermann
    Hanusch, Ursula
    Prager, Rudolf
    Sourij, Harald
    Hemetsberger, Margit
    Ratzinger, Michaela
    Ebenbichler, Christoph
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 359 - 360
  • [32] Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG
    Hillen, Uwe
    Leiter, Ulrike
    Haase, Sylvie
    Kaufmann, Roland
    Becker, Juergen
    Gutzmer, Ralf
    Terheyden, Patrick
    Krause-Bergmann, Albrecht
    Schulze, Hans-Joachim
    Hassel, Jessica
    Lahner, Nina
    Wollina, Uwe
    Ziller, Fabian
    Utikal, Jochen
    Hafner, Christine
    Ulrich, Jens
    Machens, Hans-Guenther
    Weishaupt, Carsten
    Hauschild, Axel
    Mohr, Peter
    Pfoehler, Claudia
    Maurer, Jan
    Wolff, Patrick
    Windemuth-Kieselbach, Christine
    Schadendorf, Dirk
    Livingstone, Elisabeth
    EUROPEAN JOURNAL OF CANCER, 2018, 96 : 34 - 43
  • [33] Updated results of a prospective non-interventional study of everolimus in Germany after failure of the first VEGFR-TKI in metastatic renal cell carcinoma
    Bergmann, L.
    Goebell, P.-J.
    Kube, U.
    Kindler, M.
    Herrmann, E.
    Janssen, J.
    Schmitz, J.
    Weikert, S.
    Kloss, S.
    Steiner, G.
    Jakob, A.
    Staehler, M.
    Steiner, T.
    Overkamp, F.
    Guderian, G.
    Doehn, C.
    ONKOLOGIE, 2012, 35 : 203 - 203
  • [34] Olaparib in German routine clinical practice: Updated interim results of the non-interventional study C-PATROL.
    Marme, Frederik
    Hilpert, Felix
    Welslau, Manfred
    El-Balat, Ahmed
    Grischke, Eva-Maria
    Schinkothe, Timo
    Glowik, Regina
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Cabazitaxel treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) in daily practice - Interim analysis of the non-interventional SCOPE study
    Bokemeyer, C.
    Amram, M. -L.
    Stoiber, F.
    Gschwend, J. E.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 224 - 224
  • [36] Olaparib in German routine clinical practice: Updated interim results of the non-interventional study c-patrol
    Sehouli, J.
    Hilpert, F.
    Welslau, M.
    Schinkoethe, T.
    Glowik, R.
    Marme, F.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 120 - 120
  • [37] Cabazitaxel treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) in daily practice: Interim analysis of the non-interventional SCOPE study
    Bokemeyer, C.
    Amram, M-L.
    Stoiber, F.
    Gschwend, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S517 - S517
  • [38] Patient Expectations in the Treatment of Painful Diabetic Polyneuropathy: Results from a Non-Interventional Study
    Schneider, Edith
    Ziegler, Dan
    Wilhelm, Stefan
    Schacht, Alexander
    Birklein, Frank
    PAIN MEDICINE, 2014, 15 (04) : 671 - 681
  • [39] First interim results of IDELA PASS: a prospective non-interventional post authorization safety study of idelalisib in Germany
    Abenhardt, W.
    Knauf, W.
    Eissmann, P.
    Hucke, N.
    van Troostenburg, A.
    Watzke, S.
    Hoechstetter, M.
    Rummel, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 139 - +
  • [40] Subcutaneous rituximab in patients with DLBCL and follicular NHL - First interim results from the non-interventional study MabSCale
    Duerig, J.
    Azeh, I
    Blumenstengel, K.
    Gerhardt, A.
    Haenel, M.
    Hapke, G.
    Hensel, M.
    Hessling, J.
    Hoeffkes, H. -G
    Hurtz, H. -J
    Ritter, M.
    Staib, P.
    Uhlig, J.
    Marquardt, M.
    Krumm, K.
    von Weikersthal, Fischer L.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 156 - 156
12345